CCL21 and breast carcinoma: Similarly, in an orthotopic mouse model of breast cancer, intratumoral administration of CCL21 significantly increased the proportion of T cells, NK cells, and DCs within the tumor, reduced the size of the tumor and extended the survival time of tumor‐bearing mice.212